Quantbot Technologies’s Neuropace NPCE Stock Holding History

Quantbot Technologies’s Portfolio NPCE Stock Details NPCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,128	Closed	-$34.8K	–	2002
2025 Q2	$34.8K	Buy	+3,128	New	+$39.1K	﹤0.01%	1511

Other funds holding NPCE

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

KLP

Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Quantbot Technologies's NPCE Position: Q3 2025 in Review

Quantbot Technologies sold out of Neuropace (NPCE) in Q3 2025, closing a stake of 3,128 shares — an estimated $34.8K sold.

Quantbot Technologies first reported a position in NPCE in Q2 2025 and held it in 1 quarter. The position peaked at $34.8K in Q2 2025. 80 funds tracked by Wall St. Rank hold NPCE as of Q3 2025.

Quantbot Technologies reported no remaining Neuropace position as of Q3 2025 after selling out during the quarter.
Quantbot Technologies sold 3,128 Neuropace shares in Q3 2025, an estimated $34.8K.
Quantbot Technologies first reported a position in Neuropace in Q2 2025 and held it in 1 quarter.
Quantbot Technologies's Neuropace position peaked at $34.8K in Q2 2025.
80 funds tracked by Wall St. Rank held Neuropace as of Q3 2025.

Based on Quantbot Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.